Literature DB >> 8234172

Rates of systemic degradation and reticuloendothelial system (RES) uptake of thermosensitive liposome encapsulating cisplatin in rats.

K Iga1, Y Ogawa, H Toguchi.   

Abstract

The systemic degradation and reticuloendothelial system (RES) uptake of cisplatin (CDDP)-encapsulated thermosensitive liposomes composed of dipalmitoylphosphatidylcholine (DPPC) and distearoylphosphatidylcholine (DSPC) (DPPC/DSPC = 9/1, 7/3, and 5/5, w/w) after intravenous administration to rats were examined by measuring the platinum (Pt) levels in the blood and RES (liver and spleen). The blood liposome level profile showed first-order rate elimination for each liposome administration. The elimination rate (Kel) was faster when the content of DSPC was lower (Kel: 1.3/hr for 9/1-liposomes, 0.7/hr for 7/3-liposomes, 0.5/hr for 5/5-liposomes). On the other hand, the RES liposome level profile showed distribution of liposomes followed by elimination therefrom. The RES level of the liposomes was lower when the content of DSPC was smaller (maximal level: 25% for 9/1-liposomes at 1 hr, 32% for 7/3-liposomes at 1 hr, 37% for 5/5-liposomes at 2 hr). The kinetic analysis demonstrated that the RES uptake rate (Kres) was almost the same among the liposomes (0.4/hr), while the systemic degradation rate (Kdeg; Kel-Kres) became larger as the content of DSPC decreased (0.9/hr for 9/1-liposomes, 0.3/hr for 7/3-liposomes, and 0.1/hr for 5/5-liposomes) and that the RES liposome distribution amount was dependent not only on the Kres but also on the Kdeg and the rate of RES liposome degradation. The Kdeg for each type of liposome corresponded with the systemic CDDP release rate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234172     DOI: 10.1023/a:1018925931294

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Non-Michaelis-Menten type hepatic uptake of liposomes in the rat.

Authors:  H Harashima; Y Kume; C Yamane; H Kiwada
Journal:  J Pharm Pharmacol       Date:  1992-09       Impact factor: 3.765

Review 2.  [Reconstruction of drug dispositions in vivo from in vitro studies based on physiological pharmacokinetic modeling: from low-molecular weight drugs to polypeptide compounds].

Authors:  Y Sugiyama
Journal:  Yakugaku Zasshi       Date:  1989-04       Impact factor: 0.302

3.  Theoretic aspects of pharmacokinetic drug interactions.

Authors:  J R Gillette; K S Pang
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Estimation of drug absorption rates using a deconvolution method with nonequal sampling times.

Authors:  K Iga; Y Ogawa; T Yashiki; T Shimamoto
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

5.  Design of liposomes for enhanced local release of drugs by hyperthermia.

Authors:  M B Yatvin; J N Weinstein; W H Dennis; R Blumenthal
Journal:  Science       Date:  1978-12-22       Impact factor: 47.728

Review 6.  Fate and behavior of liposomes in vivo: a review of controlling factors.

Authors:  J H Senior
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

7.  Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).

Authors:  J Lautersztain; R Perez-Soler; A R Khokhar; R A Newman; G Lopez-Berestein
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Authors:  P A Steerenberg; G Storm; G de Groot; A Claessen; J J Bergers; M A Franken; Q G van Hoesel; K L Wubs; W H de Jong
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

9.  Increased tumor cisplatin levels in heated tumors in mice after administration of thermosensitive, large unilamellar vesicles encapsulating cisplatin.

Authors:  K Iga; N Hamaguchi; Y Igari; Y Ogawa; H Toguchi; T Shimamoto
Journal:  J Pharm Sci       Date:  1991-06       Impact factor: 3.534

10.  Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Authors:  A Rahman; D Carmichael; M Harris; J K Roh
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

  10 in total
  1 in total

1.  Rates of systemic degradation and reticuloendothelial system uptake of calcein in the dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols in mice.

Authors:  X R Qi; Y Maitani; T Nagai
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.